As of Feb 17
| +0.31 / +2.07%|
The 1 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a -21.41% decrease from the last price of 15.27.
The current consensus among 1 polled investment analysts is to Hold stock in NewLink Genetics Corp. This rating has held steady since February, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.